A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)

Hospital San Pedro de Alcantara, Cáceres

Duke University Medical Center, Durham

Levine Cancer Institute, Charlotte

Hospital Universitario de Salamanca, Salamanca

Vanderbilt University Medical Center, Nashville

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

IU Simon Cancer Center, Indianapolis

START Midwest, Grand Rapids

Mayo Clinic, Rochester

Northwestern University Feinberg School of Medicine, Chicago

University of Texas MD Anderson Cancer Center, Houston

University of Southern California, Norris Comprehensive Cancer Center, Los Angeles

Fred Hutchinson Cancer Research Center, Seattle

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Seoul Saint Mary's Hospital, Seoul

Severance Hospital, Seoul

Hospital General Universitario de Alicante, Alicante